I'rom Group Co., Ltd.

TSE:2372 Rapport sur les actions

Capitalisation boursière : JP¥33.6b

I'rom Group Résultats passés

Passé contrôle des critères 1/6

I'rom Group has been growing earnings at an average annual rate of 11.7%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 13.1% per year. I'rom Group's return on equity is 6.2%, and it has net margins of 4.6%.

Informations clés

11.7%

Taux de croissance des bénéfices

11.2%

Taux de croissance du BPA

Healthcare Croissance de l'industrie7.9%
Taux de croissance des recettes13.1%
Rendement des fonds propres6.2%
Marge nette4.6%
Prochaine mise à jour des résultats05 Nov 2024

Mises à jour récentes des performances passées

Recent updates

Ventilation des recettes et des dépenses

Comment I'rom Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

TSE:2372 Recettes, dépenses et bénéfices (JPY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 2417,6978156,039606
31 Mar 2417,7401,4155,688682
31 Dec 2317,3231,2765,558885
30 Sep 2317,3901,6515,246730
30 Jun 2318,2182,3664,915940
31 Mar 2318,3512,5424,708859
31 Dec 2217,9132,4214,1501,077
30 Sep 2218,4933,2214,594635
30 Jun 2217,0972,7704,151682
31 Mar 2215,6931,9614,126582
31 Dec 2115,1002,1154,2660
30 Sep 2114,6671,7773,591318
30 Jun 2114,0851,5803,6370
31 Mar 2112,9061,3733,3600
31 Dec 2012,7971,7543,1660
30 Sep 2010,9611,2823,0270
30 Jun 2010,3921,1163,0490
31 Mar 2010,5931,2363,0530
31 Dec 199,9027433,176-139
30 Sep 1910,5266463,0800
30 Jun 1910,7009182,9700
31 Mar 1910,5789122,8340
31 Dec 1810,3847882,75050
30 Sep 189,4598572,715-59
30 Jun 189,2224892,6290
31 Mar 188,6211,5582,4390
31 Dec 178,1091,8732,257-10
30 Sep 176,9491,6601,985-2
30 Jun 175,6401,6061,7080
31 Mar 174,8902041,5870
31 Dec 164,384-1061,377-14
30 Sep 164,246-3261,517-11
30 Jun 164,148-8251,8930
31 Mar 164,114-8681,9650
31 Dec 154,164-9602,150-14
30 Sep 153,988-1,0901,967-8
30 Jun 153,890-8841,6250
31 Mar 154,134-6061,5660
31 Dec 143,747-6761,559127
30 Sep 143,922-4881,55480
30 Jun 144,277-2441,5170
31 Mar 144,011-2941,4070
31 Dec 134,172-11,2380

Des revenus de qualité: 2372 has a large one-off gain of ¥272.0M impacting its last 12 months of financial results to 30th June, 2024.

Augmentation de la marge bénéficiaire: 2372's current net profit margins (4.6%) are lower than last year (13%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 2372's earnings have grown by 11.7% per year over the past 5 years.

Accélération de la croissance: 2372's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Bénéfices par rapport au secteur d'activité: 2372 had negative earnings growth (-65.6%) over the past year, making it difficult to compare to the Healthcare industry average (9.6%).


Rendement des fonds propres

ROE élevé: 2372's Return on Equity (6.2%) is considered low.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé